CRC has an immunosuppressive TME which prevents the event of an effective reaction to ICB therapies. You can find Hence an urgent need to detect the methods reprogram this suppressive TME so that you can boost immunotherapy efficacy. In The present research, we utilised CRISPR KO screens to discover